nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—nerve—acquired immunodeficiency syndrome	0.0286	0.13	CbGeAlD
Cysteamine—SST—blood plasma—acquired immunodeficiency syndrome	0.0216	0.0982	CbGeAlD
Cysteamine—MPO—saliva—acquired immunodeficiency syndrome	0.02	0.0908	CbGeAlD
Cysteamine—NPY2R—nervous system—acquired immunodeficiency syndrome	0.0165	0.0748	CbGeAlD
Cysteamine—NPY2R—central nervous system—acquired immunodeficiency syndrome	0.0159	0.072	CbGeAlD
Cysteamine—NPY2R—brain—acquired immunodeficiency syndrome	0.0126	0.0572	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.012	0.0381	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.0117	0.0373	CbGpPWpGaD
Cysteamine—MPO—endothelium—acquired immunodeficiency syndrome	0.00981	0.0445	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00969	0.0309	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00929	0.0296	CbGpPWpGaD
Cysteamine—MPO—blood plasma—acquired immunodeficiency syndrome	0.00871	0.0395	CbGeAlD
Cysteamine—SST—lymphoid tissue—acquired immunodeficiency syndrome	0.00842	0.0382	CbGeAlD
Cysteamine—SST—digestive system—acquired immunodeficiency syndrome	0.00832	0.0377	CbGeAlD
Cysteamine—SST—blood—acquired immunodeficiency syndrome	0.00792	0.036	CbGeAlD
Cysteamine—SST—spinal cord—acquired immunodeficiency syndrome	0.00763	0.0346	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.00668	0.0213	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0065	0.0207	CbGpPWpGaD
Cysteamine—SST—nervous system—acquired immunodeficiency syndrome	0.00643	0.0292	CbGeAlD
Cysteamine—NPY2R—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00628	0.02	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00623	0.0199	CbGpPWpGaD
Cysteamine—SST—central nervous system—acquired immunodeficiency syndrome	0.00619	0.0281	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00587	0.0187	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00563	0.0179	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00531	0.0169	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00509	0.0162	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00495	0.0158	CbGpPWpGaD
Cysteamine—SST—brain—acquired immunodeficiency syndrome	0.00492	0.0223	CbGeAlD
Cysteamine—SST—lymph node—acquired immunodeficiency syndrome	0.00475	0.0216	CbGeAlD
Cysteamine—NPY2R—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00474	0.0151	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00431	0.0137	CbGpPWpGaD
Cysteamine—MPO—skin of body—acquired immunodeficiency syndrome	0.00419	0.019	CbGeAlD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00394	0.0125	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00377	0.012	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00363	0.0116	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00356	0.0113	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00348	0.0111	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00341	0.0109	CbGpPWpGaD
Cysteamine—MPO—lymphoid tissue—acquired immunodeficiency syndrome	0.00339	0.0154	CbGeAlD
Cysteamine—MPO—digestive system—acquired immunodeficiency syndrome	0.00335	0.0152	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00328	0.0104	CbGpPWpGaD
Cysteamine—MPO—blood—acquired immunodeficiency syndrome	0.00319	0.0145	CbGeAlD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00314	0.01	CbGpPWpGaD
Cysteamine—MPO—bone marrow—acquired immunodeficiency syndrome	0.00309	0.014	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00308	0.00982	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00308	0.00982	CbGpPWpGaD
Cysteamine—MPO—spinal cord—acquired immunodeficiency syndrome	0.00307	0.014	CbGeAlD
Cysteamine—SST—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.003	0.00955	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00296	0.00942	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00296	0.00942	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00287	0.00916	CbGpPWpGaD
Cysteamine—MPO—lung—acquired immunodeficiency syndrome	0.0028	0.0127	CbGeAlD
Cysteamine—SST—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00277	0.00881	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.00274	0.00872	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00271	0.00864	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00267	0.00852	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00265	0.00845	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.0026	0.00829	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.0026	0.00829	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0026	0.00828	CbGpPWpGaD
Cysteamine—MPO—nervous system—acquired immunodeficiency syndrome	0.00259	0.0118	CbGeAlD
Cysteamine—SST—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00254	0.00809	CbGpPWpGaD
Cysteamine—MPO—central nervous system—acquired immunodeficiency syndrome	0.00249	0.0113	CbGeAlD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00249	0.00795	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00249	0.00795	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00246	0.00784	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00243	0.00776	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00243	0.00775	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00235	0.00747	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00233	0.00743	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00231	0.00737	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00225	0.00717	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.0022	0.00701	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00211	0.00673	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00211	0.00672	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00211	0.00672	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00207	0.00659	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00207	0.00659	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00203	0.00646	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00202	0.00645	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00198	0.00632	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00198	0.00632	CbGpPWpGaD
Cysteamine—MPO—brain—acquired immunodeficiency syndrome	0.00198	0.00899	CbGeAlD
Cysteamine—SST—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00198	0.00631	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00196	0.00623	CbGpPWpGaD
Cysteamine—MPO—lymph node—acquired immunodeficiency syndrome	0.00191	0.00868	CbGeAlD
Cysteamine—NPY2R—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.0019	0.00604	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00185	0.0059	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.0018	0.00573	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00178	0.00568	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00178	0.00566	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00172	0.00547	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00171	0.00545	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00167	0.00534	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00161	0.00512	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00159	0.00505	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00157	0.00502	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00157	0.00502	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00157	0.00501	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00157	0.00499	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00154	0.0049	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00151	0.00481	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00151	0.00481	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00151	0.00481	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.0015	0.00478	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00147	0.0047	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00144	0.00458	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00142	0.00452	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.0014	0.00445	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00139	0.00443	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00136	0.00433	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00133	0.00425	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.00131	0.00418	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00127	0.00406	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.0012	0.00382	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00115	0.00366	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00113	0.00361	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00111	0.00354	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00108	0.00344	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.00106	0.00337	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.00104	0.00332	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00103	0.0033	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.00101	0.00323	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.00101	0.00323	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.00101	0.00323	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00095	0.00303	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000947	0.00302	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000911	0.0029	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000909	0.0029	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000909	0.0029	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000907	0.00289	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00089	0.00284	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00089	0.00284	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000871	0.00278	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000871	0.00278	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00086	0.00274	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000853	0.00272	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000853	0.00272	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.00084	0.00268	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000825	0.00263	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000824	0.00263	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000822	0.00262	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000818	0.00261	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000808	0.00258	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000808	0.00258	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000788	0.00251	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000775	0.00247	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000775	0.00247	CbGpPWpGaD
Cysteamine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000718	0.00154	CcSEcCtD
Cysteamine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000714	0.00153	CcSEcCtD
Cysteamine—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000714	0.00153	CcSEcCtD
Cysteamine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000714	0.00153	CcSEcCtD
Cysteamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000713	0.00153	CcSEcCtD
Cysteamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000713	0.00153	CcSEcCtD
Cysteamine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000711	0.00153	CcSEcCtD
Cysteamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00071	0.00152	CcSEcCtD
Cysteamine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00071	0.00152	CcSEcCtD
Cysteamine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00071	0.00152	CcSEcCtD
Cysteamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000709	0.00152	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000709	0.00152	CcSEcCtD
Cysteamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000708	0.00152	CcSEcCtD
Cysteamine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000708	0.00152	CcSEcCtD
Cysteamine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000706	0.00152	CcSEcCtD
Cysteamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000706	0.00152	CcSEcCtD
Cysteamine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000705	0.00151	CcSEcCtD
Cysteamine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000703	0.00151	CcSEcCtD
Cysteamine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000701	0.0015	CcSEcCtD
Cysteamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000697	0.0015	CcSEcCtD
Cysteamine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000697	0.0015	CcSEcCtD
Cysteamine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000695	0.00149	CcSEcCtD
Cysteamine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000692	0.00149	CcSEcCtD
Cysteamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000692	0.00149	CcSEcCtD
Cysteamine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00069	0.00148	CcSEcCtD
Cysteamine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00069	0.00148	CcSEcCtD
Cysteamine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000685	0.00147	CcSEcCtD
Cysteamine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000685	0.00147	CcSEcCtD
Cysteamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000683	0.00147	CcSEcCtD
Cysteamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000681	0.00146	CcSEcCtD
Cysteamine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000681	0.00146	CcSEcCtD
Cysteamine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000681	0.00146	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000677	0.00216	CbGpPWpGaD
Cysteamine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000677	0.00145	CcSEcCtD
Cysteamine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000674	0.00145	CcSEcCtD
Cysteamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000672	0.00144	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000672	0.00144	CcSEcCtD
Cysteamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000671	0.00144	CcSEcCtD
Cysteamine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000671	0.00144	CcSEcCtD
Cysteamine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000669	0.00144	CcSEcCtD
Cysteamine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000668	0.00143	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000667	0.00213	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000666	0.00212	CbGpPWpGaD
Cysteamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000666	0.00143	CcSEcCtD
Cysteamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000665	0.00143	CcSEcCtD
Cysteamine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000664	0.00143	CcSEcCtD
Cysteamine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000664	0.00142	CcSEcCtD
Cysteamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000662	0.00142	CcSEcCtD
Cysteamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000661	0.00142	CcSEcCtD
Cysteamine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00066	0.00142	CcSEcCtD
Cysteamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00066	0.00142	CcSEcCtD
Cysteamine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00066	0.00142	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000658	0.0021	CbGpPWpGaD
Cysteamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000656	0.00141	CcSEcCtD
Cysteamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000656	0.00141	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000655	0.00209	CbGpPWpGaD
Cysteamine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000652	0.0014	CcSEcCtD
Cysteamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00065	0.0014	CcSEcCtD
Cysteamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00065	0.0014	CcSEcCtD
Cysteamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00065	0.00139	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000649	0.00207	CbGpPWpGaD
Cysteamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000646	0.00139	CcSEcCtD
Cysteamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000645	0.00138	CcSEcCtD
Cysteamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000644	0.00138	CcSEcCtD
Cysteamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000643	0.00138	CcSEcCtD
Cysteamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000642	0.00138	CcSEcCtD
Cysteamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000641	0.00138	CcSEcCtD
Cysteamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00064	0.00137	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000639	0.00204	CbGpPWpGaD
Cysteamine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000639	0.00137	CcSEcCtD
Cysteamine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000638	0.00137	CcSEcCtD
Cysteamine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000637	0.00137	CcSEcCtD
Cysteamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000636	0.00137	CcSEcCtD
Cysteamine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000636	0.00136	CcSEcCtD
Cysteamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000635	0.00136	CcSEcCtD
Cysteamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000633	0.00136	CcSEcCtD
Cysteamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000629	0.00135	CcSEcCtD
Cysteamine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000629	0.00135	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000627	0.00135	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000625	0.00134	CcSEcCtD
Cysteamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000624	0.00134	CcSEcCtD
Cysteamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000624	0.00134	CcSEcCtD
Cysteamine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000624	0.00134	CcSEcCtD
Cysteamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000619	0.00133	CcSEcCtD
Cysteamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000618	0.00133	CcSEcCtD
Cysteamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000618	0.00133	CcSEcCtD
Cysteamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000616	0.00132	CcSEcCtD
Cysteamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000615	0.00132	CcSEcCtD
Cysteamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000615	0.00132	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000615	0.00196	CbGpPWpGaD
Cysteamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000615	0.00132	CcSEcCtD
Cysteamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000613	0.00132	CcSEcCtD
Cysteamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000613	0.00132	CcSEcCtD
Cysteamine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00061	0.00131	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00061	0.00194	CbGpPWpGaD
Cysteamine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000609	0.00131	CcSEcCtD
Cysteamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000608	0.00131	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000606	0.00193	CbGpPWpGaD
Cysteamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000604	0.0013	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000603	0.0013	CcSEcCtD
Cysteamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000602	0.00129	CcSEcCtD
Cysteamine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0006	0.00129	CcSEcCtD
Cysteamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000597	0.00128	CcSEcCtD
Cysteamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000595	0.00128	CcSEcCtD
Cysteamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000594	0.00128	CcSEcCtD
Cysteamine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000593	0.00127	CcSEcCtD
Cysteamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000592	0.00127	CcSEcCtD
Cysteamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000592	0.00127	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00059	0.00127	CcSEcCtD
Cysteamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00059	0.00127	CcSEcCtD
Cysteamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00059	0.00127	CcSEcCtD
Cysteamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00059	0.00127	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000589	0.00188	CbGpPWpGaD
Cysteamine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000588	0.00126	CcSEcCtD
Cysteamine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000587	0.00126	CcSEcCtD
Cysteamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000585	0.00126	CcSEcCtD
Cysteamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000585	0.00126	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000585	0.00186	CbGpPWpGaD
Cysteamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000584	0.00125	CcSEcCtD
Cysteamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000583	0.00125	CcSEcCtD
Cysteamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000582	0.00125	CcSEcCtD
Cysteamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000581	0.00125	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000581	0.00185	CbGpPWpGaD
Cysteamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000577	0.00124	CcSEcCtD
Cysteamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000576	0.00124	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000576	0.00124	CcSEcCtD
Cysteamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000575	0.00123	CcSEcCtD
Cysteamine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000573	0.00123	CcSEcCtD
Cysteamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000572	0.00123	CcSEcCtD
Cysteamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000572	0.00123	CcSEcCtD
Cysteamine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000571	0.00123	CcSEcCtD
Cysteamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000571	0.00123	CcSEcCtD
Cysteamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000569	0.00122	CcSEcCtD
Cysteamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000569	0.00122	CcSEcCtD
Cysteamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000566	0.00122	CcSEcCtD
Cysteamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000566	0.00121	CcSEcCtD
Cysteamine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000566	0.00121	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000565	0.00121	CcSEcCtD
Cysteamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000565	0.00121	CcSEcCtD
Cysteamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.00121	CcSEcCtD
Cysteamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000564	0.00121	CcSEcCtD
Cysteamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000564	0.00121	CcSEcCtD
Cysteamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000563	0.00121	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000561	0.00179	CbGpPWpGaD
Cysteamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000561	0.0012	CcSEcCtD
Cysteamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000561	0.0012	CcSEcCtD
Cysteamine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00056	0.0012	CcSEcCtD
Cysteamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00056	0.0012	CcSEcCtD
Cysteamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000559	0.0012	CcSEcCtD
Cysteamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.0012	CcSEcCtD
Cysteamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000556	0.00119	CcSEcCtD
Cysteamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000556	0.00119	CcSEcCtD
Cysteamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.00119	CcSEcCtD
Cysteamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.00119	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000554	0.00176	CbGpPWpGaD
Cysteamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000553	0.00119	CcSEcCtD
Cysteamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000551	0.00118	CcSEcCtD
Cysteamine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000545	0.00117	CcSEcCtD
Cysteamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000543	0.00117	CcSEcCtD
Cysteamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000541	0.00116	CcSEcCtD
Cysteamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000541	0.00116	CcSEcCtD
Cysteamine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00054	0.00116	CcSEcCtD
Cysteamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000539	0.00116	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000538	0.00172	CbGpPWpGaD
Cysteamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000538	0.00115	CcSEcCtD
Cysteamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000535	0.00115	CcSEcCtD
Cysteamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000534	0.00115	CcSEcCtD
Cysteamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000533	0.00114	CcSEcCtD
Cysteamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000533	0.00114	CcSEcCtD
Cysteamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000533	0.00114	CcSEcCtD
Cysteamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000532	0.00114	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000531	0.00169	CbGpPWpGaD
Cysteamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00053	0.00114	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.000529	0.00169	CbGpPWpGaD
Cysteamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000526	0.00113	CcSEcCtD
Cysteamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000524	0.00112	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.00112	CcSEcCtD
Cysteamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000522	0.00112	CcSEcCtD
Cysteamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00052	0.00112	CcSEcCtD
Cysteamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000519	0.00111	CcSEcCtD
Cysteamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000518	0.00111	CcSEcCtD
Cysteamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000517	0.00111	CcSEcCtD
Cysteamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000517	0.00111	CcSEcCtD
Cysteamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000517	0.00111	CcSEcCtD
Cysteamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000515	0.0011	CcSEcCtD
Cysteamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000513	0.0011	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000508	0.00162	CbGpPWpGaD
Cysteamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000506	0.00109	CcSEcCtD
Cysteamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000504	0.00108	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000503	0.00108	CcSEcCtD
Cysteamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00108	CcSEcCtD
Cysteamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.00107	CcSEcCtD
Cysteamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000498	0.00107	CcSEcCtD
Cysteamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000495	0.00106	CcSEcCtD
Cysteamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000495	0.00106	CcSEcCtD
Cysteamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000495	0.00106	CcSEcCtD
Cysteamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000494	0.00106	CcSEcCtD
Cysteamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000491	0.00105	CcSEcCtD
Cysteamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000491	0.00105	CcSEcCtD
Cysteamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00049	0.00105	CcSEcCtD
Cysteamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000489	0.00105	CcSEcCtD
Cysteamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000488	0.00105	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000487	0.00155	CbGpPWpGaD
Cysteamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000483	0.00104	CcSEcCtD
Cysteamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000482	0.00103	CcSEcCtD
Cysteamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.00103	CcSEcCtD
Cysteamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00048	0.00103	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00048	0.00103	CcSEcCtD
Cysteamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.00103	CcSEcCtD
Cysteamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000479	0.00103	CcSEcCtD
Cysteamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.00103	CcSEcCtD
Cysteamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.00103	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000477	0.00152	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000477	0.00152	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000476	0.00102	CcSEcCtD
Cysteamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000475	0.00102	CcSEcCtD
Cysteamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00047	0.00101	CcSEcCtD
Cysteamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000468	0.001	CcSEcCtD
Cysteamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000463	0.000993	CcSEcCtD
Cysteamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000462	0.000992	CcSEcCtD
Cysteamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.000988	CcSEcCtD
Cysteamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00046	0.000988	CcSEcCtD
Cysteamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00046	0.000988	CcSEcCtD
Cysteamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000458	0.000983	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000458	0.00146	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000458	0.00146	CbGpPWpGaD
Cysteamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000456	0.00098	CcSEcCtD
Cysteamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000456	0.000979	CcSEcCtD
Cysteamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000454	0.000975	CcSEcCtD
Cysteamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000453	0.000973	CcSEcCtD
Cysteamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000452	0.000971	CcSEcCtD
Cysteamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000448	0.000961	CcSEcCtD
Cysteamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.000957	CcSEcCtD
Cysteamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000441	0.000948	CcSEcCtD
Cysteamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000439	0.000943	CcSEcCtD
Cysteamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000439	0.000943	CcSEcCtD
Cysteamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000435	0.000933	CcSEcCtD
Cysteamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.000932	CcSEcCtD
Cysteamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.000929	CcSEcCtD
Cysteamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000431	0.000926	CcSEcCtD
Cysteamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000431	0.000925	CcSEcCtD
Cysteamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00043	0.000923	CcSEcCtD
Cysteamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.000921	CcSEcCtD
Cysteamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000428	0.00092	CcSEcCtD
Cysteamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000418	0.000897	CcSEcCtD
Cysteamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000416	0.000893	CcSEcCtD
Cysteamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.000889	CcSEcCtD
Cysteamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000413	0.000886	CcSEcCtD
Cysteamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000412	0.000885	CcSEcCtD
Cysteamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00041	0.00088	CcSEcCtD
Cysteamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.000879	CcSEcCtD
Cysteamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000406	0.000872	CcSEcCtD
Cysteamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.0004	0.000859	CcSEcCtD
Cysteamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000399	0.000856	CcSEcCtD
Cysteamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.000855	CcSEcCtD
Cysteamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000389	0.000834	CcSEcCtD
Cysteamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000385	0.000827	CcSEcCtD
Cysteamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000385	0.000826	CcSEcCtD
Cysteamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000382	0.000819	CcSEcCtD
Cysteamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000381	0.000818	CcSEcCtD
Cysteamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00038	0.000816	CcSEcCtD
Cysteamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.000814	CcSEcCtD
Cysteamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00037	0.000795	CcSEcCtD
Cysteamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.000789	CcSEcCtD
Cysteamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.000788	CcSEcCtD
Cysteamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000367	0.000788	CcSEcCtD
Cysteamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.000783	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000363	0.00116	CbGpPWpGaD
Cysteamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.000772	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000358	0.00114	CbGpPWpGaD
Cysteamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000353	0.000758	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000352	0.00112	CbGpPWpGaD
Cysteamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.000752	CcSEcCtD
Cysteamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.000751	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000348	0.00111	CbGpPWpGaD
Cysteamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000348	0.000747	CcSEcCtD
Cysteamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000346	0.000743	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000343	0.00109	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000338	0.00108	CbGpPWpGaD
Cysteamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.000708	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000327	0.00104	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.00032	0.00102	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000314	0.001	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000307	0.000978	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000189	0.000602	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000188	0.000599	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000181	0.000578	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00018	0.000575	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000111	0.000354	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000107	0.000339	CbGpPWpGaD
